1. Home
  2. CRESY vs APMD Comparison

CRESY vs APMD Comparison

Compare CRESY & APMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$11.46

Market Cap

804.3M

Sector

Finance

ML Signal

HOLD

Logo Apnimed Inc. Common Stock

APMD

Apnimed Inc. Common Stock

N/A

Current Price

$18.87

Market Cap

895.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRESY
APMD
Founded
1936
2017
Country
Argentina
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.3M
895.5M
IPO Year
1997
2026

Fundamental Metrics

Financial Performance
Metric
CRESY
APMD
Price
$11.46
$18.87
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$15.86
★ $50.33
AVG Volume (30 Days)
201.5K
★ 380.6K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
★ 5.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.96
$136.17
Revenue Next Year
$19.02
N/A
P/E Ratio
$6.92
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.26
$16.43
52 Week High
$14.21
$35.29

Technical Indicators

Market Signals
Indicator
CRESY
APMD
Relative Strength Index (RSI) 47.97 43.61
Support Level $11.18 N/A
Resistance Level $11.74 $30.22
Average True Range (ATR) 0.39 1.64
MACD -0.05 0.28
Stochastic Oscillator 39.58 45.47

Price Performance

Historical Comparison
CRESY
APMD

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About APMD Apnimed Inc. Common Stock

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).

Share on Social Networks: